angiotensin ii, des-phe(8)- has been researched along with Cardiac Remodeling, Ventricular in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.56) | 18.2507 |
2000's | 11 (28.21) | 29.6817 |
2010's | 26 (66.67) | 24.3611 |
2020's | 1 (2.56) | 2.80 |
Authors | Studies |
---|---|
Dang, Z; Ge, R; Jin, G; Li, Z; Lu, D; Ma, L; Nan, X; Su, S | 1 |
He, Q; Huang, Y; Yang, L | 1 |
Guo, L; Han, S; He, W; Li, H; Shen, D; Wang, J; Zhang, Y | 1 |
Barbosa-da-Silva, S; de Oliveira Fraga, SR; de Oliveira Sá, G; Dos Santos Neves, V; Souza-Mello, V | 1 |
Luo, X; Ma, Q; Wu, Y; Yu, J; Zhang, L; Zhang, Y | 1 |
Bartlett, MJ; Doyle, KP; Falk, T; Hay, M; Heien, ML; Konhilas, JP; Largent-Milnes, TM; Polt, R; Rodgers, K; Vanderah, TW | 1 |
Arruda-Junior, DF; Benetti, A; Beraldo, JI; Borges-Júnior, FA; Dariolli, R; Girardi, ACC; Jensen, L; Luchi, WM; Martins, FL; Seguro, AC; Shimizu, MH | 1 |
Andrades, ME; Biolo, A; Caetano, DSL; Clausell, N; Leitão, SAT; Lopes, A; Nascimento, TG; Pinto, GH; Rohde, LEP; Soares, DDS | 1 |
Hong, L; Lin, C; Lin, L; Liu, GY; Pan, YX; Peng, WW; Wang, SZ; Zhao, XL | 1 |
Chen, Y; Sun, Y; Zhao, T; Zhao, W | 1 |
Cheng, XC; Guo, W; Hao, XQ; Li, L; Li, M; Sun, TW; Zhang, JL; Zhang, SY | 1 |
Chamsi-Pasha, MA; Shao, Z; Tang, WH | 1 |
Chen, Y; Liu, C; Liu, H; Meng, W; Sun, Y; Zhao, T; Zhao, W | 1 |
Alghamri, MS; Elased, KM; Grobe, N; Meszaros, JG; Morris, M | 1 |
Chen, YG; Hao, PP; Yang, JM; Zhang, C; Zhang, K; Zhang, MX; Zhang, Y | 1 |
Batich, CD; Byrne, BJ; Cogle, CR; Ferreira, LF; Handberg, EM; Huo, T; Pepine, CJ; Petersen, JW; Qi, Y; Rocca, DG; Rubiano, A; Ruchaya, PJ; Simmons, CS; Wate, PS; Willenberg, BJ; Wise, EA | 1 |
Barnes, CA; Constantopoulos, E; Hay, M; Konhilas, J; Samareh-Jahani, F; Uprety, AR; Vanderah, TW | 1 |
Aranha, AB; Bader, M; Callera, GE; Ferreira, AJ; Mercure, C; Reudelhuber, TL; Santos, RA; Touyz, RM; Walther, T; Yogi, A | 1 |
Chen, J; He, Q; Li, Y; Pen, W; Shou, Z; Wu, J; Zhang, P; Zhu, Y | 1 |
Basu, R; Guo, D; Kassiri, Z; Liu, PP; Oudit, GY; Penninger, JM; Scholey, JW; Wang, X; Zhong, J | 1 |
Ahmad, S; Brosnihan, KB; Chappell, MC; Ferrario, CM; Gallagher, PE; Groban, L; Tallant, EA; Varagic, J | 1 |
Arranz, C; Dominici, FP; Giani, JF; Mayer, MA; Muñoz, MC; Taira, CA; Toblli, JE; Turyn, D; Veiras, LC | 1 |
Campagnole-Santos, MJ; Guimarães, PS; Irigoyen, MC; Oliveira, LA; Santiago, NM; Santos, RA; Sirvente, RA | 1 |
Cowling, RT; Greenberg, B; Iwata, M; Yeo, SJ | 1 |
Basu, R; Bodiga, S; Guo, D; Holland, SM; Kassiri, Z; Liu, GC; Lo, J; Oudit, GY; Penninger, JM; Scholey, JW; Wang, W; Zhong, JC | 1 |
Afzal, A; Katovich, MJ; Li, H; Mocco, J; Qi, Y; Raizada, MK; Shenoy, V; Sumners, C; Wong, F | 1 |
Ann Tallant, E; Gallagher, PE; McCollum, LT | 1 |
Alenina, N; Bader, M; Campagnole-Santos, MJ; Guimarães, GG; Martins, AS; Motta, DF; Oliveira, ML; Pimenta-Velloso, EP; Santos, RA; Santos, SH | 1 |
Clarke, C; Flores-Muñoz, M; McKinney, CA; Milligan, G; Nicklin, SA | 1 |
Alzamora, AC; Campagnole-Santos, MJ; Cunha, TM; Lima, WG; Silva, ME; Souza Santos, RA | 1 |
Averill, DB; Brosnihan, KB; Ferrario, CM; Gallagher, PE; Ishiyama, Y; Tallant, EA | 1 |
Ferrario, CM; Gallagher, PE; Tallant, EA | 1 |
Grobe, JL; Katovich, MJ; Mao, H; Mecca, AP | 1 |
Gamliel-Lazarovich, A; Kaplan, M; Keidar, S | 1 |
Bolton, TA; Grobe, JL; Katovich, MJ; Lingis, M; Machado, JM; Mecca, AP; Raizada, MK; Shenoy, V; Speth, RC | 1 |
Agata, J; Hyakkoku, M; Sasaki, H; Shimamoto, K; Shinshi, Y; Taniguchi, S; Ura, N; Yoshida, H | 1 |
Lin, CS; Pan, CH | 1 |
Henning, RH; Iusuf, D; Roks, AJ; van Gilst, WH | 1 |
Linz, W; Malinski, T; Schölkens, BA; Wiemer, G; Wohlfart, P | 1 |
7 review(s) available for angiotensin ii, des-phe(8)- and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Angiotensin-converting enzyme 2 as a therapeutic target for heart failure.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Cardiovascular Agents; Heart Failure; Humans; Hypertension; Molecular Targeted Therapy; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Ventricular Remodeling | 2014 |
Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Gene Expression; Heart; Heart Failure; Humans; Molecular Targeted Therapy; Myocardium; Myofibroblasts; Organ Specificity; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Translational Research, Biomedical; Ventricular Remodeling | 2011 |
Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Blood Pressure; Cardiovascular Agents; Cardiovascular Diseases; Humans; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Ventricular Remodeling | 2013 |
ACE2 of the heart: From angiotensin I to angiotensin (1-7).
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Disease Progression; Heart Failure; Humans; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Ventricular Remodeling | 2007 |
Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Atrial Fibrillation; Endomyocardial Fibrosis; Heart Atria; Humans; Inflammation; Matrix Metalloproteinases; Models, Biological; Oxidative Stress; Peptide Fragments; ras GTPase-Activating Proteins; Signal Transduction; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta1; Ventricular Remodeling | 2008 |
Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Bone Marrow Cells; Diabetes Mellitus; Heart Diseases; Humans; Hypertension; Peptide Fragments; Renin-Angiotensin System; Ventricular Remodeling | 2008 |
Interactions among ACE, kinins and NO.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Biological Availability; Cardiovascular Diseases; Endothelium, Vascular; Humans; Hypertension; Kinins; Myocardial Ischemia; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Ventricular Remodeling | 1999 |
1 trial(s) available for angiotensin ii, des-phe(8)- and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Imidapril inhibits right ventricular remodeling induced by low ambient temperature in broiler chickens.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animal Husbandry; Animals; Chickens; Cold Temperature; Gene Expression Regulation; Heart Ventricles; Housing, Animal; Imidazolidines; Peptide Fragments; Peptidyl-Dipeptidase A; Ventricular Remodeling | 2013 |
31 other study(ies) available for angiotensin ii, des-phe(8)- and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Hypertrophy, Right Ventricular; Hypoxia; Male; Medicine, Tibetan Traditional; Peptide Fragments; Peptidyl-Dipeptidase A; Plant Preparations; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Ventricular Remodeling | 2020 |
[Regulation of angiotensin-converting enzyme 2-angiotensin (1-7)-Mas axis provides a new target for the treatment of cardiac remodeling and heart failure].
Topics: Angiotensin I; Heart Failure; Humans; Peptide Fragments; Ventricular Remodeling | 2019 |
The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Collagen; Fibrosis; Heart Function Tests; Immunohistochemistry; Male; Myocardial Infarction; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; RNA, Messenger; Ventricular Dysfunction, Left; Ventricular Remodeling | 2017 |
High-intensity interval training has beneficial effects on cardiac remodeling through local renin-angiotensin system modulation in mice fed high-fat or high-fructose diets.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Diet, High-Fat; Fructose; Gene Expression Regulation; High-Intensity Interval Training; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Peptidyl-Dipeptidase A; Random Allocation; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Ventricular Remodeling | 2017 |
[Role of ACE2-Ang (1-7)-Mas receptor axis in heart failure with preserved ejection fraction with hypertension].
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Atrial Remodeling; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Heart Failure; Humans; Hypertension; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling | 2018 |
A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction.
Topics: Angiotensin I; Animals; Behavior, Animal; Biomarkers; Brain; Cognitive Dysfunction; Dementia, Vascular; Electrocardiography; Glycosylation; Half-Life; Heart Failure; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Maze Learning; Memory; Mice; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Spatial Memory; Ventricular Remodeling | 2019 |
Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease.
Topics: Angiotensin I; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Blood Pressure; Body Weight; Cardiotonic Agents; Diastole; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Kidney; Kidney Function Tests; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Rats, Wistar; Renal Insufficiency, Chronic; Renin-Angiotensin System; Sitagliptin Phosphate; Up-Regulation; Ventricular Remodeling | 2019 |
Cardiac hypertrophy in mice submitted to a swimming protocol: influence of training volume and intensity on myocardial renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiomegaly; Hypertrophy, Left Ventricular; Male; Mice, Inbred BALB C; Myocardium; Peptide Fragments; Physical Conditioning, Animal; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Swimming; Ventricular Remodeling | 2019 |
Prehypertension exercise training attenuates hypertension and cardiac hypertrophy accompanied by temporal changes in the levels of angiotensin II and angiotensin (1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiomegaly; Diastole; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Prehypertension; Rats, Inbred SHR; Rats, Inbred WKY; Ventricular Remodeling | 2019 |
Angiotensin 1-7 promotes cardiac angiogenesis following infarction.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Female; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardium; Neovascularization, Pathologic; Neovascularization, Physiologic; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Vascular Endothelial Growth Factor D; Ventricular Remodeling | 2015 |
Autocrine and paracrine function of Angiotensin 1-7 in tissue repair during hypertension.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Autocrine Communication; Disease Models, Animal; Fibrosis; Hypertension; Kidney; Male; Myocardium; Paracrine Communication; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction; Ventricular Remodeling | 2014 |
Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin-Converting Enzyme 2; Animals; Disease Models, Animal; Enzyme Inhibitors; Glutamyl Aminopeptidase; Kinetics; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substrate Specificity; Tandem Mass Spectrometry; Ventricular Remodeling | 2014 |
Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy.
Topics: Angiotensin I; Animals; Blood Glucose; Cells, Cultured; Coculture Techniques; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Fibrosis; Heart Ventricles; Lipids; Male; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Time Factors; Transforming Growth Factor beta1; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Remodeling | 2015 |
An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in rats.
Topics: Alginates; Angiotensin I; Animals; Biocompatible Materials; Disease Models, Animal; Echocardiography; Gelatin; Glucuronic Acid; Hexuronic Acids; Hydrogels; Injections, Intralesional; Myocardial Infarction; Peptide Fragments; Rats; Rats, Sprague-Dawley; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2016 |
Cognitive impairment in heart failure: A protective role for angiotensin-(1-7).
Topics: Angiotensin I; Animals; Cognitive Dysfunction; Disease Models, Animal; Heart Failure; Inflammation; Male; Maze Learning; Mice; Mice, Inbred C57BL; Myocardial Infarction; Peptide Fragments; Ventricular Remodeling; Visual Acuity | 2017 |
Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Crosses, Genetic; Heart; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Ventricular Remodeling | 2008 |
Angiotensin (1-7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Creatinine; Heart Failure; Heart Ventricles; Kidney; Kidney Failure, Chronic; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Transforming Growth Factor beta; Ventricular Dysfunction, Left; Ventricular Remodeling | 2009 |
Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
Topics: Adaptation, Physiological; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Biphenyl Compounds; Disease Models, Animal; Enzyme Activation; Inflammation Mediators; Irbesartan; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardium; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Receptor, Angiotensin, Type 1; RNA, Messenger; Superoxides; Tetrazoles; Time Factors; Ultrasonography; Ventricular Remodeling | 2009 |
Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Receptors, G-Protein-Coupled; Renin; RNA, Messenger; Sodium Chloride, Dietary; Ventricular Dysfunction, Left; Ventricular Remodeling | 2010 |
Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Dietary Carbohydrates; Disease Models, Animal; Fructose; Hypertension; Hypertrophy, Left Ventricular; Insulin; Insulin Resistance; Male; Peptide Fragments; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2010 |
Lifetime overproduction of circulating Angiotensin-(1-7) attenuates deoxycorticosterone acetate-salt hypertension-induced cardiac dysfunction and remodeling.
Topics: Analysis of Variance; Angiotensin I; Animals; Collagen Type I; Collagen Type III; Desoxycorticosterone; Heart Function Tests; Hypertension; Hypertrophy, Left Ventricular; Immunohistochemistry; Peptide Fragments; Rats; Rats, Transgenic; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ventricular Remodeling | 2010 |
Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiomyopathy, Dilated; Disease Models, Animal; Enzyme Activation; Extracellular Matrix; Heart Failure; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; NADPH Oxidases; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Stress, Mechanical; Superoxides; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Interleukin-10; Interleukin-6; Lentivirus; Male; Myocardial Ischemia; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Renin-Angiotensin System; Transduction, Genetic; Ventricular Remodeling | 2011 |
Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Cardiomegaly; Drug Interactions; Dual Specificity Phosphatase 1; Fibrosis; Hypertension; Male; MAP Kinase Signaling System; Myocardium; Peptide Fragments; Rats; Rats, Sprague-Dawley; Up-Regulation; Vasoconstrictor Agents; Ventricular Remodeling | 2012 |
Exercise induces renin-angiotensin system unbalance and high collagen expression in the heart of Mas-deficient mice.
Topics: Angiotensin I; Angiotensin II; Animals; Collagen; Collagen Type I; Collagen Type III; Gene Expression Regulation; Heart; Hypertrophy, Left Ventricular; Male; Mice; Mice, Knockout; Peptide Fragments; Physical Conditioning, Animal; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Ventricular Remodeling | 2012 |
The nonpeptide ANG-(1-7) mimic AVE 0991 attenuates cardiac remodeling and improves baroreflex sensitivity in renovascular hypertensive rats.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Hypertension, Renovascular; Imidazoles; Kidney; Male; Myocardium; Peptide Fragments; Rats; Rats, Inbred F344; Ventricular Remodeling | 2013 |
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Cardiomyopathy, Hypertrophic; Coronary Vessels; Disease Models, Animal; Enzyme Induction; Imidazoles; Ligation; Losartan; Male; Myocardial Infarction; Myocardium; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Ventricular Remodeling | 2004 |
Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor.
Topics: Angiotensin I; Animals; Animals, Newborn; Antihypertensive Agents; Cell Division; Cells, Cultured; MAP Kinase Signaling System; Myocytes, Cardiac; Oligonucleotides, Antisense; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; RNA, Messenger; Ventricular Remodeling | 2005 |
Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension.
Topics: Angiotensin I; Animals; Blood Pressure; Cardiomegaly; Collagen; Coronary Vessels; Desoxycorticosterone; Dose-Response Relationship, Drug; Fibrosis; Heart Diseases; Hypertension; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2006 |
Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart; Hypertension; Male; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Time Factors; Transforming Growth Factor beta; Ventricular Remodeling | 2007 |
Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Gene Expression; Imidazoles; Male; Myocardium; Nitrates; Nitrites; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Tetrazoles; Ventricular Remodeling | 2006 |